Wells Fargo & Company »

Denali Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 66k 21.46
2023-09-30 $2.8M 136k 20.63
2023-06-30 $4.8M 163k 29.51
2022-12-31 $1.8M 65k 27.81
2022-09-30 $2.0M 65k 30.69
2022-06-30 $2.0M 69k 28.57
2022-03-31 $3.5M 110k 32.18
2021-12-31 $6.5M 144k 44.98
2021-09-30 $8.3M 165k 50.18
2021-06-30 $12M 148k 78.45
2021-03-31 $6.6M 116k 57.10
2020-12-31 $10M 124k 83.82
2020-09-30 $3.1M 86k 35.90
2020-06-30 $1.9M 80k 24.27
2020-03-31 $2.8M 159k 17.52
2019-12-31 $2.5M 145k 17.43
2019-09-30 $2.2M 146k 15.32
2019-06-30 $2.9M 139k 20.77
2019-03-31 $1.7M 73k 23.23
2018-12-31 $1.5M 75k 20.67
2018-09-30 $1.5M 69k 21.76
2018-06-30 $855k 56k 15.28
2018-03-31 $1.1M 56k 19.74
2017-12-31 $621k 40k 15.64